ESC 365 - Insulin treatment is associated with increased risk of device-treated ventricular tachyarrhythmia in patients with diabetes and heart failure

ESC Premium Access

Insulin treatment is associated with increased risk of device-treated ventricular tachyarrhythmia in patients with diabetes and heart failure

Session: Blockbusters from the Young - Cutting edge in heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Miss S. Glud Heiredal (Copenhagen, DK)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Miss Sofie Nancy Glud Heiredal

Gentofte University Hospital, Copenhagen (Denmark)

0 follower

2 more presentations in this session

Feasibility and validation of routine CMR-based phenotyping for the prediction of heart failure admission or death in patients with systolic dysfunction

Speaker: Ms A. Cornhill (Calgary, CA)

Expression profile of microRNAs in cardiac tissue from pediatric patients with heart failure (HF) supported by Ventricular Assist Device and their involvement in pathophysiological mechanisms of HF.

Speaker: Doctor C. Caselli (Pisa, IT)

Access the full session

Blockbusters from the Young - Cutting edge in heart failure

Speakers: Miss S. Glud Heiredal, Ms A. Cornhill, Doctor C. Caselli

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources